Home Up Contents Euro Prices Order Info Distributors

 larynx and pharynx cancer

GENTAUR Belgium : + 32 2 7325688 France : 01 43250150 Italy : 02 36006593 • Germany : +49 241 6085 13140

Up

 

TEL: +32 16 58 90 45

Fax :+ 32 16 50 90 45

GENTAUR Europe

tel+32 2 732 5688
fax+32 2 732 4414
info@genprice.com
Av. de l' Armée 68
B-1040 BRUSSELS
BELGIUM

GENTAUR France

tel 01 43 25 01 50

fax01 43 25 01 60

9, rue Lagrange

75005 PARIS

FRANCE

GENTAUR Italy

tel 02 36 00 65 93

fax 02 36 00 65 94

20135 MILANO

ITALY

GENTAUR Germany

tel +49 241 6085 13140

fax +49 241 6085 33033

Forckenbeckstraße 6,

D-52074 Aachen

GERMANY


 

 


 
   Category Human tissue array
   Cat. No. CH
   Product description larynx and pharynx cancer
   Data sheet CH1xls
CH1
    
   Images
  general_information
   No. of samples 60
   Text
Current version: CH1
larynx or pharynx cancer: 60 cores

Price : 5 slide for 600 €

CH1   Human larynx and pharynx cancer
             
  Age Sex Location Diagnosis TNM Stage
1 43 M larynx, pyriform sinus  SCC*, moderately differentiated T4N2M0 ⅣA
2 55 M larynx, subglottic SCC, moderately differentiated T4N0M0 ⅣA
3 72 M larynx, supraglottic SCC, moderately differentiated T3N0M0
4 63 M esophagus SCC, basaloid type T4N0M0 ⅣA
5 67 M larynx, transglottic SCC, well differentiated T4N2bM0 ⅣA
6 63 M larynx, pyriform sinus SCC, moderately differentiated T4N2cM0 ⅣA
7 60 M larynx, supraglottic SCC, moderately differentiated T4N2cM0 ⅣA
8 61 M larynx, glottic SCC, moderately differentiated T4N0M0 ⅣA
9 66 M larynx, glottic SCC, moderately differentiated T4N0M0 ⅣA
10 56 M larynx, glottic SCC, well differentiated T1N0M0
11 62 M larynx, supraglottic SCC, moderately differentiated T3N2M0 ⅣA
12 56 M larynx, pyriform sinus  SCC, moderately differentiated T4N2bM0 ⅣA
13 54 M larynx, supraglottic SCC, well differentiated T3N0M0
14 48 M larynx, transglottic SCC, well differentiated T3N0M0
15 61 M larynx, supraglottic SCC, well differentiated T3N0M0
16 66 M soft tissue of neck SCC, well differentiated of hypopharynx T4N0M0
17 51 M larynx, supraglottic SCC, moderately differentiated T4N2cM0 ⅣA
18 46 M soft tissue, neck SCC of hypopharynx T2N3M0 ⅣB
19 52 M larynx, supraglottic SCC, moderately differentiated T2N0M0
20 52 F Nasal cavity undifferentiated carcinoma T4NxM0 ⅣA
21 64 M larynx, transglottic basaloid SCC T3N1M0
22 28 F lymph node undifferentiated carcinoma from nasopharynx T1N2cMx 0
23 63 M Nasopharynx undifferentiated carcinoma TxN2M1 ⅣC
24 77 M Neck undifferentiated carcinoma TxN2M0 ⅣA
25 51 M larynx, transglottic SCC, well differentiated T4N2M0 ⅣA
26 51 M hypopharynx SCC, moderately differentiated TxN1M0
27 59 M nasal cavity SCC, poorly differentiated T4N0M0 ⅣA
28 55 M larynx, subglottic SCC, moderately differentiated T3N0M0
29 60 M larynx, transglottic Larynx, SCC, well differentiated T4N0M0 ⅣA
30 70 M oropharynx undifferentiated carcinoma T1N2aM0 ⅣA
31 55